TO TOP

Prof. Dr. Konstanze F. Winklhofer

Institute of Biochemistry and Pathobiochemistry
Molecular Cell Biology
E-Mail
Tel.: +49-(0)234-32-28428

Research

The Winklhofer lab focuses on mechanisms underlying neurodegenerative diseases on the molecular, cellular and systems level. A major topic is the role of the ubiquitin system in maintaining neuronal proteostasis and integrity. Another focus are mitochondria as key organelles in orchestrating stress response and adaptive pathways as well as interorganellar communication at the interface of neuroprotective and innate immune signaling.

To address these research interests experimentally, we are using state-of-the-art techniques in cell biology, molecular biology, protein biochemistry, and advanced light microscopy, including super-resolution microscopy and live cell imaging.

News

  • GBM Compact - Focus on RNA structure & dynamics - Read more
  • Open positions: We are hiring a Microscopy Scientist - Read more

Mitochondria as sources and targets of cellular signaling

Mitochondria are multifunctional organelles that, in addition to providing energy, coordinate various signaling pathways essential for maintaining cellular homeostasis. Their suitability as signaling organelles arises from a unique combination of structural and functional plasticity, allowing them to sense, integrate, and respond to a wide variety of cellular cues. Mitochondria are highly dynamic, they can fuse and divide, pinch off vesicles and move around, facilitating interorganellar communication. Moreover, their ultrastructural peculiarities enable a tight regulation of fluxes across the inner and outer mitochondrial membranes. As organelles of proteobacterial origin, mitochondria harbor danger signals and require protection from the consequences of membrane damage by efficient quality control mechanisms. However, mitochondria have also been co-opted by eukaryotic cells to react to cellular damage and to promote effective immune responses. In a recent review, we provided an overview of our current knowledge of mitochondria as both sources and targets of cellular signaling.


TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo Sequestration

Optineurin is an autophagy receptor which plays an important role in the selective degradation of mitochondria, protein aggregates, and intracellular pathogens. It recognizes ubiquitylated cargo by its UBAN (ubiquitin-binding in ABIN and NEMO) domain and recruits the autophagic machinery through its LIR (LC3-interacting region) domain. Phosphorylation of Optineurin by TBK1 (Tank-binding kinase 1) increases the binding of Optineurin to both ubiquitin chains and lipidated microtubule-associated protein light chain 3 (LC3). Optineurin has been reported to form foci at ubiquitylated cargo, but the underlying mechanism and how these foci are linked to selective autophagy has remained largely unknown. Our work revealed that phosphorylation of Optineurin by TBK1 induces the formation of filaments that phase separate upon binding to linear polyubiquitin. LC3 anchored to unilamellar vesicles co-partitions into Optineurin/polyubiquitin condensates, resulting in the local deformation of the vesicle membrane. Thus, the condensation of filamentous Optineurin with ubiquitylated cargo promotes the nucleation of cargo and its subsequent alignment with LC3-positive nascent autophagosomes, suggesting that co-condensation processes ensure directionality in selective autophagy.


NEMO promotes the autophagic clearance of α-Synuclein aggregates by co-condensation with p62

NEMO is a ubiquitin-binding protein implicated in canonical NF-κB pathway activation in innate immune signaling, cell death regulation and host-pathogen interactions. In this study, we identified a yet unknown function of NEMO in proteostasis regulation by promoting autophagosomal clearance of protein aggregates. NEMO-deficient cells accumulate misfolded proteins upon proteotoxic stress and are vulnerable to proteostasis challenges. Moreover, a patient with a mutation in the NEMO-encoding IKBKG gene resulting in defective binding of NEMO to linear ubiquitin chains, developed a widespread mixed brain proteinopathy, including α-synuclein, tau and TDP-43 pathology. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes the local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentrations required for ubiquitin-dependent phase transition of p62. In summary, NEMO reshapes the aggregate surface for efficient autophagosomal clearance by providing a mobile phase at the aggregate interphase that favors co-condensation with p62.


Mitochondria as a platform for ubiquitin signaling

Mitochondria are increasingly recognized as cellular hubs to orchestrate signaling pathways that regulate metabolism, redox homeostasis, and cell fate decisions. Recent research revealed a role of mitochondria also in innate immune signaling, however, the mechanisms of how mitochondria affect signal transduction are poorly understood. Our work revealed that the NF-ĸB pathway activated by TNF employs mitochondria as a platform for signal amplification and shuttling of activated NF-ĸB to the nucleus. TNF treatment induces the recruitment of HOIP, the catalytic component of the linear ubiquitin chain assembly complex (LUBAC), and its substrate NEMO to the outer mitochondrial membrane, where M1- and K63-linked ubiquitin chains are generated. NF-ĸB is locally activated and transported to the nucleus by mitochondria, leading to an increase in mitochondria-nucleus contact sites in a HOIP-dependent manner. Notably, TNF-induced stabilization of the mitochondrial kinase PINK1 contributes to signal amplification by antagonizing the M1-ubiquitin-specific deubiquitinase OTULIN.


Ubiquitin-induced phase separation of NEMO in canonical NF-κB signaling

The NF-κB essential modulator NEMO is the core regulatory component of the inhibitor of κB kinase (IKK) complex, which is a critical checkpoint in canonical NF-κB signaling downstream of innate and adaptive immune receptors. In response to various stimuli, such as tumor necrosis factor (TNF) or interleukin-1β (IL-1β), NEMO binds to linear or M1-linked ubiquitin chains generated by LUBAC, promoting its oligomerization and subsequent activation of the associated kinases. We observed that M1-ubiquitin chains induce phase separation of NEMO and the formation of NEMO assemblies in cells after exposure to IL-1β. Phase separation is promoted by both binding of NEMO to linear ubiquitin chains and covalent linkage of M1-ubiquitin to NEMO and is essential but not sufficient for its phase separation. Supporting the functional relevance of NEMO phase separation in signaling, a pathogenic NEMO mutant, which is impaired in both binding and linkage to linear ubiquitin chains, does not undergo phase separation and is defective in mediating IL-1β-induced NF-κB activation.

Stabilization of LUBAC by PACRC promotes TNF signaling

The Parkin coregulated gene (PACRG) shares a bi-directional promoter with Parkin (PRKN), which encodes an E3 ubiquitin ligase. Parkin is important in mitochondrial quality control and protection against stress, we therefore tested whether PACRG also affects these pathways. PACRG does not play a role in mitophagy but does play a role in tumor necrosis factor (TNF) signaling. Similarly to Parkin, PACRG promotes NF-κB activation in response to TNF stimulation. TNF-induced nuclear translocation of the NF-κB subunit p65 and NF-κB-dependent transcription are decreased in PACRG-deficient cells. Defective canonical NF-κB activation in the absence of PACRG is accompanied by a decrease in linear ubiquitylation mediated by the linear ubiquitin chain assembly complex (LUBAC), which is composed of the two E3 ubiquitin ligases HOIP and HOIL-1L and the adaptor protein SHARPIN. Upon TNF stimulation, PACRG is recruited to the activated TNF receptor complex and interacts with LUBAC components. PACRG can functionally replace SHARPIN in this context. In SHARPIN-deficient cells, PACRG prevents LUBAC destabilization, restores HOIP-dependent linear ubiquitylation, and protects cells from TNF-induced apoptosis. This function of PACRG in positively regulating TNF signaling may help to explain the association of PACRG and PRKN polymorphisms with an increased susceptibility to intracellular pathogens.


Linear ubiquitylation regulates protein quality control: A role of LUBAC in Huntington’s disease

Neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain. Insights into protein quality control mechanisms to prevent neuronal dysfunction and cell death are crucial in developing causal therapies. We discovered that various diseases-associated protein aggregates are modified by the linear ubiquitin chain assembly complex (LUBAC). HOIP, the catalytic component of LUBAC is recruited to misfolded Huntingtin in a p97/VCP-dependent manner, resulting in the assembly of linear polyubiquitin. As a consequence, the interactive surface of misfolded Huntingtin species is shielded from unwanted interactions, for example with the low complexity sequence domain-containing transcription factor Sp1, and proteasomal degradation of misfolded Huntingtin is facilitated. Notably, all three core LUBAC components are transcriptionally regulated by Sp1, linking defective LUBAC expression to Huntington's disease. In support of a protective activity of linear ubiquitylation, silencing of OTULIN, a deubiquitinase with unique specificity for linear polyubiquitin, decreases proteotoxicity, whereas silencing of HOIP has the opposite effect. These findings identify linear ubiquitylation as a protein quality control mechanism and hence a novel target for disease-modifying strategies in proteinopathies.

Recent Publications

  • Meichsner A, Bader V, Winklhofer KFMitochondria as sources and targets of cellular signaling. Mol Cell. 2026 Feb 5;86(3):503-521. PMID: 41610856 Review. doi.org/10.1016/j.molcel.2026.01.008
  • Herrera MG, Kühn L, Jungbluth L, Bader V, Krause LJ, Kartte D, Adriaenssens E, Martens S, Tatzelt J, Sachse C, Winklhofer KF. (2025) TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo Sequestration Adv Sci (Weinh.) 2025 Dec 17:e09927. DOI: 10.1002/advs.202509927
  • Fecher C, Sodmann A, Schlott F, Jaepel J, Schmitt F, Lengfelder I, Bischler T, Nieswandt B, Winklhofer KF, Blum R (2025) Resting Ca2+ fluxes protect cells from fast mitochondrial fragmentation, cell stress responses, and immediate transcriptional reprogramming. Cell Mol Life Sci. 2025 Jun 14;82(1):238. doi: 10.1007/s00018-025-05745-2.
  • Grover P, Dec R, Mamashli F, Winter R, Winklhofer KF, Tatzelt J (2025) Soluble N-Terminal Domain of the Prion Protein Interferes with Fibrillization of α-Synuclein to Form Off-Pathway Assemblies that Lack Cellular Seeding Activity. ACS Chem Neurosci. 2025 May 7. doi: 10.1021/acschemneuro.5c00085.
  • Hoffrogge R, Karachunskaya A, Heitmann N, Pedreiturria X, Klöster K, Bader V, Winklhofer KF, Hamacher M, Klebl B, Gold R, Dinkel K, Kleiter I, Faissner S (2025) The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm. Front Immunol. 2025 Apr 16:16:1554999. doi: 10.3389/fimmu.2025.1554999
  • Mueller-Buehl C, Pakush J, Bader V, Winklhofer KF, Mark MD, Faissner A (2025) Combined loss of brevican, neurocan, tenascin-C and tenascin-R leads to impaired fear retrieval due to perineuronal net loss. Sci Rep. 2025 Feb 14;15(1):5528. doi: 10.1038/s41598-025-89580-2
  • Joaqim M, Altin S, Bulimaga MB, Simoes T, Nolte H, Bader V, Franchino CA, Plouzennec S, Szczepanowska K, Marchesan E, Hofmann K, Krüger M, Ziviani E, Trifunovic A, Chevrollier A, Winklhofer KF, Motori E, Odenthal M, Mafalda EH (2025) Mitofusin 2 displays fusion - independent roles in proteostasis surveillance. Nat Commun. 2025 Feb 10;16(1):1501. doi: 10.1038/s41467-025-56673-5
  • Gogte K, Mamashli F, Herrera MG, Kriegler S, Bader V, Kamps J, Grover P, Winter R, Winklhofer KF, Tatzelt J (2025) Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases. Proc Natl Acad Sci USA. 2025 Jan 7;122(1):e2415250121. doi: 10.1073/pnas.2415250121
  • Zein L, Dietrich M, Balta D, Bader V, Scheuer C, Zellner S, Weinelt N, Vandrey J, Mari MC, Behrends C, Zunke F, Winklhofer KF, Van Wijk SJL (2025) Linear ubiquitination at damaged lysosomes induces local NFKB activation and controls cell survival. Autophagy. 2025 Jan 2:1-21. doi: 10.1080/15548627.2024.2443945
  • Jagst M, Gömer A, Augustyniak S, Klöhn M, Rehm A, Ulrich RG, Bader V, Winklhofer KF, Brüggemann Y, Gold R, Gisevius B, Todt D, Steinmann E (2024) Modeling extrahepatic hepatitis E virus infection in induced human primary neurons. Proc Natl Acad Sci USA. 2024 Nov 19;121(47):e2411434121. doi: 10.1073/pnas.2411434121

  • Kamps J, Yuste-Checa P, Mamashli F, Schmitz M, Herrera MG, da Silva Correia SM, Gogte K, Bader V, Zerr I, Hartl FU, Bracher A, Winklhofer KF, Tatzelt J (2024) Regulated proteolysis induces aberrant phase transition of biomolecular condensates into aggregates; a protective role for the chaperone Clusterin. J Mol Biol. 2024 Dec 1;436(23):168839. doi: 10.1016/j.jmb.2024168839
  • Cihankaya H, Bader V, Winklhofer KF, Vorgerd M, Matschke J, Stahlke S, Theiss C, Matschke V (2024) Elevated NLRP3 inflammasome activation is associated with motor neuron degeneration in ALS. Cells. 2024 Jun 7;13(12):995. doi: 10.103390/cells13120995
  • Wißing MH, Meister TL, Nocke MK, Gömer A, Masovic M, Knegendorf L, Brüggemann Y, Bader V, Siddharta A, Bock CT, Ploss A, Kenny SP, Winklhofer KF, Behrendt P, Wedemeyer H, Steinmann E, Todt D (2024) Genetic determinants of host-and virus-derived insertions for hepatitis E virus replication. Nat Commun. 2024 Jun 6;15(1):4855. doi: 10.1038/s41467-024-49219-8
  • Gisevius B, Duscha A, Poschmann G, Stühler K, Motte J, Fisse AL, Augustyniak S, Rehm A, Renk P, Böse C, Hubert D, Peters K, Jagst M, Gömer A, Todt D, Bader V, Tokic M, Hirschberg S, Krogias C, Trampe N, Coutourier C, Winnesberg C, Steinmann E, Winklhofer KF, Gold R, Haghikia A (2024) Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons. Brain Commun. 2024 Jun 3;6(3):fcae182. doi: 10.1093/braincomms/fcae182
  • Kamps J, Bader V, Winklhofer KF, Tatzelt J (2024) Liquid-liquid phase separation of the prion protein is regulated by the octarepeat domain independently of histidines and copper. J Biol Chem. 2024 Jun;300(6):107310. doi: 10.1016/j.jbc.2024.107310
  • Banik P, Ray K, Kamps J, Chen QY, Luesch H, Winklhofer KF, Tatzelt J (2024) VCP/p97 mediates nuclear targeting of non-ER-imported prion protein to maintain proteostasis. Life Sci Alliance 2024 Apr 3; 7(6):e202302456. doi: 10.26508/lsa.202302456
  • Polido SA, Stuani C, Voigt A, Banik P, Kamps J, Bader V, Grover P, Krause LJ, Zerr I, Matschke J, Glatzel M, Winklhofer KF, Buratti E, Tatzelt J (2024) Cross seeding by prion protein inactivates TDP-43. Brain 2024 Jan 4; 147(1):240-254. doi: 10.1093/brain/awad289
  • Furthmann N, Bader V, Angersbach L, Blusch A, Goel S, Sanchez-Vicente A, Krause LJ, Chaban SA, Grover P, Trinkaus VA, van Well EM, Jaugstetter M, Tschulik K, Damgaard RB, Saft C, Ellrichmann G, Gold R, Koch A, Englert B, Westenberger A, Klein C, Jungbluth L, Sachse C, Behrends C, Glatzel M, Hartl FU, Nakumara K, Christine CW, Huang EJ, Tatzelt J, Winklhofer KF. (2023) NEMO α -Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62. Nat. Commun. Dez 19, 2023. doi: 10.1038/s41467-023-44033-0
  • Goel S, Oliva R, Jeganathan S, Bader V, Krause LJ, Kriegler S, Stender ID, Christine CW, Nakamura K, Hoffmann JE, Winter R, Tatzelt J*, Winklhofer KF* (2023) Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling. Life Sci Alliance Jan 31, 2023. doi: 10.26508/lsa.202201607
    * - corresponding author
  • Wu Z, Berlemann LA, Bader V, Sehr DA, Dawin E, Covallero A, Meschede J, Angersbach L, Showkat C, Michaelis JB, Münch C, Rieger B, Namgaladze D, Herrera MG, Fiesel FC, Springer W, Mendes M, Stepien J, Barkovits K, Marcus K, Sickmann A, Dittmar G, Busch KB, Riedel D, Brini M, Tatzelt J, Cali T, Winklhofer KF. (2022) LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF-κB to the nucleus. EMBO J. 18: e112006. doi: 10.15252/embj.2022112006.